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Recently, the interest in the synthesis of 3,4-dihydropyrimidin-
2(1H)-ones and their derivatives is increasing tremendously
because of their pharmacological and therapeutic properties
such as calcium channel blockers, antihypertensive agents,
a1a-antagonists and neuropeptide Y(NPY) antagonists (Atwal
et al., 1991). They are also known to possess interesting biolog-
ical activities such as antiallergic, antibacterial, antifungal,antitumor, anti-inﬂammatory, antiviral and anticancer activi-
ties (Kamaljit et al., 2011). The ﬁrst synthetic method for the
preparation of 3,4-dihydropyrimidine-2(1H)-ones (DHPMs)
was reported by Biginelli. It involves the one-pot three compo-
nent condensation of b-dicarbonyl compounds, aldehydes, and
urea or thiourea in ethanol under strongly acidic conditions.
This reaction often requires harsh conditions, long reaction
times and affords low yields in the case of substituted aromatic
and aliphatic aldehydes (Atwal et al., 1989).
In view of the pharmaceutical importance of these com-
pounds, recently many methods have been developed such as
ultrasound irradiation (Ji-Tai et al., 2003), microwave irradia-
tion (Banik et al., 2007), Lewis and protic acid promoters such
as lanthanide triﬂate (Ma et al., 2000), strontium(II) triﬂate
(Su et al., 2005), boric acid (Tu et al., 2003), KSF montmoril-
lonite (Haixia et al., 2000), CuCl2 (Mirza-Aghayan et al.,
2010), SnCl2Æ2H2O (Dennis et al., 2004), triphenylphosphine
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4b: R = 2-Cl-C6H4, X = O 5b: R = 2-Cl-C6H4, X = S
4c: R = 4-Cl-C6H4, X = O 5c: R = 4-Cl-C6H4, X = S
4d: R = 4-OCH3-C6H4, X = O 5d: R = 4-OCH3-C6H4, X = S
4e: R = 3,4-(OCH3)2-C6H3, X = O 5e: R = 3,4-(OCH3)2-C6H3, X = S
4f: R = 4-CH3-C6H4, X = O 5f: R = 4-CH3-C6H4, X = S
4g: R = 4-OH-C6H4, X = O 5g: R = 4-OH-C6H4, X = S
4h: R = 3-NO2- C6H4, X = O 5h: R = 3-NO2- C6H4, X = S
4i: R = 4-N(CH3)2-C6H4, X = O 5i: R = 4-N(CH3)2-C6H4, X = S
4j: R = 4-OH-3-OCH3-C6H3, X = O 5j: R = 4-OH-3-OCH3-C6H3, X = S
Scheme 1 Synthesis of fused 3,4-dihydropyrimidin-2(1H)-ones and thiones.
S222 B. Janardhan et al.(Debache et al., 2008), Mn(OAc)3Æ2H2O (Kumar et al., 2001),
sodium selenate (Rahim et al., 2009), silicasulfuric acid (Salehi
et al., 2003), polyphosphate ester (Fabio and Kappe, 2001),
indion-130 (Akshay et al., 2009), formic acid (Cheng and Qi,
2007) and ionic liquid (Peng and Deng, 2001) promoted reac-
tions. Many of these reported methods suffer from one or sev-
eral drawbacks such as low yield, long reaction time, tedious
workup, harsh reaction conditions and use of large quantity
of expensive reagents. To avoid these limitations, we have
developed an efﬁcient method for the synthesis of fused 3,4-
dihydropyrimidin-2(1H)-ones and thiones under solvent free
conditions using poly(4-vinylpyridinium)hydrogen sulfate
(P(4-VPH)HSO4) as Bronsted acid catalyst.
2. Results and discussions
In continuation of our studies on the synthesis of Biginelli like
scaffolds using novel catalysts (Janardhan et al., 2012; Kumar
et al., 2005), herein we describe a simple and efﬁcient method
for the synthesis of fused 3,4-dihydropyrimidin-2(1H)-ones
(4a–j) and thiones (5a–j) by a three component cyclocondensa-OH3C
O
H2N NH
O
1 2a 3a
CHO
Scheme 2 Synthesis of 3,4,5,6-tetrahydro-8-mettion reaction of 6-methoxy-1-tetralone (1), aromatic aldehydes
(2a–j) and urea (3a) or thiourea (3b) using P(4-VPH)HSO4 as
the catalyst under neat conditions with excellent yields
(Scheme 1). The catalyst P(4-VPH)HSO4 was prepared accord-
ing to the literature procedure (Khaligh, 2012).
Initially, to know the optimistic conditions a model reac-
tion of 6-methoxy-1-tetralone with benzaldehyde and urea
(Scheme 2) was carried out at different temperatures without
and with the variant amount of catalyst under solvent-free
conditions. In the absence of catalyst the yield of the product
4a was observed only in trace amounts even at 150 C, in the
presence of catalyst the yield of the product 4a gradually in-
creases with an increase in the amount of catalyst and temper-
ature and observed maximum yield at 120 C with 0.015 g of
catalyst (Table 1). Further increment in temperature and the
amount of catalyst has not shown any effect on the product
yield and reaction time. At these optimistic conditions
(120 C, 0.015 g of catalyst) we synthesized various fused 3,4-
dihydropyrimidin-2(1H)-ones (4a–j) and thiones (5a–j) with
excellent yields, the results are postulated in Table 2. After
completion of the reaction the catalyst was recovered, washed2 N
H
NH
O
OH3C
P(4-VPH)HSO4
Solvent-free
4a
hoxy-4-phenylbenzo[h]quinazolin-2(1H)-one.
Table 1 The effect of temperature and the amount of P(4-VPH)HSO4 on 3,4,5,6-tetrahydro-8-methoxy-4-phenylbenzo[h]quinazolin-
2(1H)-one (4a) yields.
Entry Amount of catalyst (g) Temp. (C) Time (min)/[h] Yielda (%)
1 – RT [12] –
2 – 80 [6] Trace
3 – 120 [6] Trace
4 – 150 [6] Trace
5 0.01 RT [2] Trace
6 0.01 80 [1] 67
7 0.01 120 [1] 78
8 0.01 150 [1] 78
9 0.015 120 (20) 94
10 0.02 120 (20) 94
a Isolated yield.
Table 2 Synthesis of fused 3,4-dihydropyrimidin-2(1H)-ones (4a–j) and thiones (5a–j).
Analog Aldehyde X Time (min) Yielda (%)
4a Benzaldehyde O 20 94
4b 2-Chloro benzaldehyde O 15 91
4c 4-Chloro benzaldehyde O 10 96
4d 4-Methoxy benzaldehyde O 15 88
4e 3,4-Dimethoxy benzaldehyde O 15 90
4f 4-Methyl benzaldehyde O 20 90
4g 4-Hydroxy benzaldehyde O 20 86
4h 3-Nitro benzaldehyde O 30 88
4i 4-(Dimethylamino) benzaldehyde O 30 87
4j 4-Hydroxy-3-methoxy benzaldehyde O 25 92
5a Benzaldehyde S 15 92
5b 2-Chloro benzaldehyde S 10 92
5c 4-Chloro benzaldehyde S 10 95
5d 4-Methoxy benzaldehyde S 15 91
5e 3,4-Dimethoxy benzaldehyde S 15 90
5f 4-Methyl benzaldehyde S 15 89
5g 4-Hydroxy benzaldehyde S 20 89
5h 3-Nitro benzaldehyde S 20 87
5i 4-(Dimethylamino)benzaldehyde S 20 86
5j 4-Hydroxy-3-methoxy benzaldehyde S 10 90
Reaction conditions: 6-methoxy-1-tetralone (1 mmol), aryl aldehyde (1 mmol), urea/thiourea (1.2 mmol) and P(4-VPH)HSO4 (0.015 g), 120 C,
neat conditions.
a Isolated yield.
Table 3 Effect of catalysts on the yield of 3,4,5,6-tetrahydro-
8-methoxy-4-phenylbenzo[h]quinazolin-2-(1H)-one (4a).
Entry Catalyst Time Yielda (%)
1 P(4-VPH)HSO4 20 min 94
2 Cellulose sulfuric acid 3 h 88
3 Silica sulfuric acid 3 h 85
4 Sulfuric acid 4 h 54
5 Hydrochloric acid 4 h 42
a Isolated yield.
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reactions without signiﬁcant loss in its activity. For example,
the reaction of 6-methoxy-1-tetralone, benzaldehyde and urea
gave the corresponding 3,4-dihydropyrimidin-2(1H)-one 4a in
94%, 93%, 92%, 92% and 90% yields over additional ﬁve
cycles.The efﬁciency of P(4-VPH)HSO4 was compared with differ-
ent acid catalysts (cellulose sulfuric acid, silica sulfuric acid,
sulfuric acid and hydrochloric acid) under solvent free condi-
tions at 120 C, and observed the maximum yield of the prod-
uct with P(4-VPH)HSO4 in shorter reaction times (Table 3).
All the synthesized compounds were characterized by their
analytical and spectroscopic data.
3. Experimental
Melting points were determined in open capillaries using a Stu-
art SMP30 apparatus (Bibby Scientiﬁc Limited, Staffordshire
ST15 0SA, UK) and are uncorrected. The progress of the
reaction was monitored by thin layer chromatography with
F254 silica-gel precoated sheets (Merck, Darmstadt, Germany)
using hexane/ethyl acetate 8/2 as eluent; UV light and iodine
vapor are used for detection. IR spectra were recorded on a
Thermo Nicolet Nexus 670 spectrometer (Thermo Scientiﬁc
Ltd., Wisconsin, USA) using KBr pellets. The C, H and N
S224 B. Janardhan et al.analyses of the compounds were done on a Carlo Erba modal
EA1108 (Triad Scientiﬁc Ltd., New Jersey, USA); 1H NMR
and 13C NMR spectra were obtained at 300 and 75 MHz,
respectively, on a Bruker spectrometer (Bruker Corporation
Ltd., Germany) using TMS as an internal standard. Mass
spectra were recorded on a Jeol JMSD-300 spectrometer (Jeol
Ltd., Tokyo, Japan).
3.1. General procedure for the synthesis of 4(a–j) and 5(a–j)
To a mixture of 6-methoxy-1-tetralone (1 mmol), aromatic
aldehyde (1 mmol) and urea or thiourea (1.2 mmol); P(4-
VPH)HSO4 (0.015 g) was added and heated at 120 C under
neat conditions for an appropriate time as shown in Table 2.
After completion of the reaction as indicated by TLC, 5 mL
of ethanol was added and the mixture was stirred at room tem-
perature for an additional 10 min. The residue (catalyst) was
separated by ﬁltration and the ﬁltrate was concentrated under
reduced pressure, the crude product was crystallized from eth-
anol to afford the pure product. The catalyst separated was
washed with dichloromethane, dried and reused for subse-
quent runs.
3.2. Spectroscopic data
3.2.1. 3,4,5,6-Tetrahydro-8-methoxy-4-phenylbenzo[h]quinaz
olin-2(1H)-one (4a)
Pale yellow solid; yield: 94%; mp: 255–258 C; IR (KBr, cm1)
tmax: 3332, 3232, 3120, 2955, 2834, 1681, 1235;
1H NMR
(CDCl3): d 1.90 (m, 1H), 2.08 (m, 1H), 2.71 (m, 2H), 3.80 (s,
3H), 5.07 (s, 1H), 6.50 (s, 1H), 6.77 (m, 2H), 7.11 (d,
J= 6.3 Hz, 2H), 7.34 (m, 5H); 13C NMR (CDCl3): 158.8,
153.2, 145.1, 137.5, 128.6, 127.8, 127.4, 127.1, 122.5, 121.4,
113.6, 110.9, 105.0, 58.4, 55.1, 28.0, 23.5; MS: m/z= 306
(M+); Anal. Calcd for C19H18N2O2: C, 74.49; H, 5.92; N,
9.14. Found: C, 74.21; H, 6.13; N, 9.32.
3.2.2. 4-(2-Chlorophenyl)-3,4,5,6-tetrahydro-8-methoxybenzo
[h]quinazolin-2(1H)-one (4b)
White solid; yield: 91%; mp: 297–299 C; IR (KBr, cm1) tmax:
3392, 3235, 3110, 2954, 2825, 1673, 1217, 735; 1H NMR
(CDCl3): d 1.98 (m, 1H), 2.20 (m, 1H), 2.77 (m, 2H), 3.82 (s,
3H), 5.02 (s, 1H), 6.49 (d, J= 6.3 Hz, 2H), 6.78 (m, 2H),
7.11 (d, J= 6.9 Hz, 2H), 7.43 (m, 2H) 8.48 (s, 1H); 13C
NMR (CDCl3): 158.6, 153.0, 144.7, 137.4, 132.4, 128.7,
128.5, 127.8, 127.6, 126.7, 122.6, 121.5, 113.8, 110.9, 104.8,
55.0, 50.3, 27.9, 23.7; MS: m/z= 341 (M+1); Anal. Calcd
for C19H17ClN2O2: C, 66.96; H, 5.03; N, 8.22. Found: C,
66.67; H, 5.26; N, 8.41.
3.2.3. 4-(4-Chlorophenyl)-3,4,5,6-tetrahydro-8-methoxybenzo
[h]quinazolin-2(1H)-one (4c)
White solid; yield: 96%; mp: 260–263 C; IR (KBr, cm1) tmax:
3365, 3220, 3115, 2941, 2828, 1692, 1247, 713; 1H NMR
(DMSO-d6): d 1.73 (m, 1H), 2.09 (m, 1H), 2.60 (m, 2H), 3.73
(s, 3H), 4.92 (s, 1H), 6.75 (s, 2H), 7.24 (s, 1H), 7.33 (d,
J= 6.3 Hz, 2H), 7.42 (d, J= 6.3 Hz, 2H), 7.50 (d,
J= 6.9 Hz, 1H), 8.49 (s, 1H); 13C NMR (DMSO-d6): 158.7,
153.1, 143.2, 137.4, 131.9, 128.7, 128.5, 127.7, 122.5, 121.5,
113.7, 110.8, 104.9, 58.3, 55.0, 27.9, 23.3; MS: m/z= 341
(M+1); Anal. Calcd for C19H17ClN2O2: C, 66.96; H, 5.03;
N, 8.22. Found: C, 66.62; H, 5.27; N, 8.39.3.2.4. 3,4,5,6-Tetrahydro-8-methoxy-4-(4-methoxyphenyl)
benzo[h]quinazolin-2(1H)-one (4d)
Yellow solid; yield: 88%; mp: 199–201 C; IR (KBr, cm1)
tmax: 3372, 3251, 3112, 2941, 2825, 1675, 1235, 1192;
1H
NMR (CDCl3): d 1.74 (m, 1H), 2.06 (m, 1H), 2.71 (m, 2H),
3.81 (s, 3H), 3.86 (s, 3H), 5.05 (s, 1H), 6.76 (m, 5H), 7.15 (d,
J= 6.3 Hz, 2H), 7.67 (s, 1H), 8.56 (s, 1H); 13C NMR (CDCl3):
158.9, 158.3, 153.1, 138.4, 137.4, 128.1, 127.7, 122.3, 121.9,
114.1, 113.9, 111.6, 105.3, 58.6, 55.4, 55.2, 27.2, 23.8; MS: m/
z= 336 (M+); Anal. Calcd for C20H20N2O3: C, 71.41; H,
5.99; N, 8.33. Found: C, 71.19; H, 6.13; N, 8.37.
3.2.5. 3,4,5,6-Tetrahydro-8-methoxy-4-(3,4-dimethoxyphenyl)
benzo[h]quinazolin-2(1H)-one (4e)
White solid; yield: 90%; mp: 148–150 C; IR (KBr, cm1) tmax:
3365, 3228, 3117, 2941, 2820, 1698, 1220, 1185; 1H NMR
(CDCl3): d 1.72 (m, 1H), 2.08 (m, 1H), 2.68 (m, 2H), 3.75 (s,
3H), 3.88 (s, 6H), 4.98 (s, 1H), 6.78 (m, 5H), 7.16 (d,
J= 6.3 Hz, 1H), 7.68 (s, 1H), 8.58 (s, 1H); 13C NMR (CDCl3):
159.6, 154.5, 149.6, 147.4, 138.4, 138.4, 127.9, 124.1, 121.5,
120.4, 115.1, 114.7, 112.1, 111.1, 105.7, 59.5, 55.3, 54.9, 27.1,
23.6; MS: m/z= 366 (M+); Anal. Calcd for C21H22N2O4: C,
68.84; H, 6.05; N, 7.65. Found: C, 68.71; H, 6.24; N, 7.44.
3.2.6. 3,4,5,6-Tetrahydro-8-methoxy-4-p-tolylbenzo[h]quina
zolin-2(1H)-one (4f)
Yellow solid; yield: 90%; mp: 258–260 C; IR (KBr, cm1)
tmax: 3390, 3218, 3125, 2915, 2834, 1670, 1212;
1H NMR
(CDCl3): d 1.94 (m, 1H), 2.08 (m, 1H), 2.42 (s, 3H), 2.69 (m,
2H), 3.80 (s, 3H), 5.02 (s, 1H), 6.64 (m, 4H), 7.10 (d,
J= 6.6 Hz, 2H), 7.35 (m, 2H) 8.54 (s, 1H); 13C NMR
(CDCl3): 159.9, 154.2, 142.1, 137.4, 136.0, 128.9, 127.7,
127.0, 122.5, 121.6, 113.7, 111.8, 104.8, 58.3, 55.1, 27.7, 24.5
23.7; MS: m/z= 321(M+1); Anal. Calcd for C20H20N2O2:
C, 74.98; H, 6.29; N, 8.74. Found: C, 74.57; H, 6.51; N, 8.87.
3.2.7. 3,4,5,6-Tetrahydro-4-(4-hydroxyphenyl)-8-methoxy
benzo[h]quinazolin-2(1H)-one (4g)
Pale yellow solid; yield: 86%; mp: 275–277 C; IR (KBr, cm1)
tmax: 3425, 3370, 3236, 3115, 2920, 2814, 1654, 1230;
1H NMR
(CDCl3): d 1.92 (m, 1H), 2.07 (m, 1H), 2.65 (m, 1H), 2.75 (m,
1H), 3.81 (s, 3H), 4.96 (s, 1H), 6.72 (m, 4H), 7.16 (d,
J= 6.3 Hz, 2H), 7.33 (d, J= 6.6 Hz, 1H), 8.03 (s, 1H), 8.30
(s, 1H), 8.93 (s, 1H); 13C NMR (CDCl3): 158.7, 156.1, 153.1,
137.7, 137.4, 128.7, 127.5, 122.6, 121.5, 115.7, 114.2, 110.9,
104.5, 58.7, 55.5, 27.9, 23.5; MS: m/z= 322 (M+); Anal.
Calcd for C19H18N2O3: C, 70.79; H, 5.63; N, 8.69. Found:
C, 70.91; H, 5.77; N, 8.35.
3.2.8. 3,4,5,6-Tetrahydro-8-methoxy-4-(3-nitrophenyl)benzo
[h]quinazolin-2(1H)-one (4h)
Yellow solid; yield: 88%; mp: 254–256 C; IR (KBr, cm1)
tmax: 3404, 3334, 3242, 3107, 2927, 1670, 1517, 1269;
1H
NMR (DMSO-d6): d 1.75 (m, 1H), 2.15 (m, 1H), 2.61 (m,
2H), 3.74 (s, 3H), 5.13 (s, 1H), 6.77 (s, 2H), 7.37 (s, 1H),
7.53 (d, J= 6.9 Hz, 1H), 7.69 (d, J= 6.3 Hz, 1H), 7.79 (d,
J= 6.3 Hz, 1H), 8.15 (m, 2H), 8.60 (s, 1H); 13C NMR
(DMSO-d6): 159.1, 155.2, 148.2, 146.0, 138.3, 133.2, 129.5,
127.9, 124.5, 122.3, 121.7, 118.7, 113.4, 110.8, 105.9, 57.3,
54.9, 28.0, 23.4; MS: m/z= 352 (M+1); Anal. Calcd for
C19H17N3O4: C, 64.95; H, 4.88; N, 11.96. Found: C, 64.74;
H, 4.91; N, 12.08.
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methoxybenzo[h]quinazolin-2(1H)-one (4i)
Brown solid; yield: 87%; mp: 298–300 C; IR (KBr, cm1)
tmax: 3395, 3222, 3152, 2912, 2839, 1682, 1222, 1153;
1H
NMR (CDCl3): d 1.91 (m, 1H), 2.07 (m, 1H), 2.71 (m, 2H),
3.07 (s, 6H), 3.87 (s, 3H), 5.03 (s, 1H), 6.84 (m, 5H), 7.37 (d,
J= 6.3 Hz, 2H), 7.47 (s, 1H); 8.76 (s, 1H); 13C NMR (CDCl3):
159.7, 153.5, 147.2, 137.4, 134.6, 128.0, 127.8, 123.5, 122.5,
114.1, 113.7, 111.8, 106.9, 58.6, 55.3, 42.4, 29.1, 23.7; MS: m/
z= 350 (M+1); Anal. Calcd for C21H23N3O2: C, 72.18; H,
6.63; N, 12.03. Found: C, 72.47; H, 6,46; N, 12.17.
3.2.10. 3,4,5,6-Tetrahydro-4-(4-hydroxy-3-methoxyphenyl)-8-
methoxybenzo[h]quinazolin-2(1H)-one (4j)
Pale yellow solid; yield: 92%; mp: 271–273 C; IR (KBr, cm1)
tmax: 3417, 3386, 3219, 3124, 2946, 2810, 1698, 1247, 1167;
1H
NMR (CDCl3): d 1.80 (m, 1H), 2.14 (m, 1H), 2.58 (m, 1H),
2.69 (m, 1H), 3.76 (s, 3H), 3.80 (s, 3H), 4.95 (s, 1H), 7.01
(m, 6H), 8.00 (s, 1H), 8.31 (s, 1H), 8.99 (s, 1H); 13C NMR
(CDCl3): 158.8, 155.1, 151.2, 143.3, 138.7, 137.4, 127.7,
122.4, 121.5, 120.8, 116.7, 113.7, 112.5, 110.8, 104.9, 58.6,
56.4, 55.3, 27.9, 24.1; MS: m/z= 352 (M+); Anal. Calcd for
C20H20N2O4: C, 68.17; H, 5.72; N, 7.95. Found: C, 68.33; H,
5.64; N, 8.07.
3.2.11. 3,4,5,6-Tetrahydro-8-methoxy-4-phenylbenzo[h]quina
zolin-2(1H)-thione (5a)
White solid; yield: 92%; mp: 272–274 C; IR (KBr, cm1) tmax:
3379, 3161, 2968, 1672, 1564, 1197, 1136; 1H NMR (CDCl3): d
1.81 (m, 1H), 2.10 (m, 1H), 2.65 (m, 2H), 3.76 (s, 3H), 5.01 (s,
1H), 6.67 (m, 4H), 7.10 (d, J= 6.3 Hz, 2H), 7.36 (m, 3H), 9.02
(s, 1H); 13C NMR (CDCl3): 174.3, 159.0, 143.8, 137.5, 128.7,
127.2, 126.9, 126.8, 123.0, 120.5, 113.9, 110.9, 107.8, 57.8,
55.2, 27.6, 23.5; MS: m/z= 322 (M+); Anal. Calcd for
C19H18N2OS: C, 70.78; H, 5.63; N, 8.69. Found: C, 70.54;
H, 5.81; N, 8.87.
3.2.12. 4-(2-Chlorophenyl)-3,4,5,6-tetrahydro-8-methoxy
benzo[h]quinazolin-2(1H)-thione (5b)
White solid; yield: 92%; mp: 270–272 C; IR (KBr, cm1) tmax:
3196, 2928, 2845, 1675, 1180, 1085, 732; 1H NMR (CDCl3): d
1.80 (m, 1H), 2.16 (m, 1H), 2.66 (m, 2H), 3.81 (s, 3H), 4.96 (s,
1H), 6.74 (m, 4H), 7.13 (d, J= 6.3 Hz, 2H), 7.44 (m, 2H), 8.98
(s, 1H); 13C NMR (CDCl3): 174.1, 158.7, 142.0, 138.2, 132.5,
128.7, 128.5, 128.3, 126.8, 126.7, 123.5, 120.7, 113.9, 110.8,
108.1, 56.1, 55.0, 27.5, 23.7; MS: m/z= 356 (M+); Anal.
Calcd for C19H17ClN2OS: C, 63.95; H, 4.80; N, 7.85. Found:
C, 63.57; H, 4.93; N, 7.99.
3.2.13. 4-(4-Chlorophenyl)-3,4,5,6-tetrahydro-8-methoxy
benzo[h]quinazolin-2(1H)-thione (5c)
Yellow solid; yield: 95%; mp: 240–243 C; IR (KBr, cm1)
tmax: 3198, 2928, 2830, 1677, 1187, 1087, 741;
1H NMR
(DMSO-d6): d 1.81 (m, 1H), 2.15 (m, 1H), 2.60 (m, 2H), 3.74
(s, 3H), 4.95 (s, 1H), 6.76 (s, 2H), 7.32 (d, J= 6.3 Hz, 2H),
7.45 (d, J= 6.3 Hz, 2H), 7.63 (d, J= 6.9 Hz, 1H), 9.05 (s,
1H), 9.71 (s, 1H); 13C NMR (DMSO-d6): 174.2, 158.9, 141.9,
137.5, 132.4, 128.8, 128.6, 126.7, 123.1, 120.4, 113.9, 110.8,
107.9, 57.7, 55.1, 27.6, 23.4; MS: m/z= 357 (M+1); Anal.
Calcd for C19H17ClN2OS: C, 63.95; H, 4.80; N, 7.85. Found:
C, 63.71; H, 4.67; N, 7.92.3.2.14. 3,4,5,6-Tetrahydro-8-methoxy-4-(4-methoxy
phenyl)benzo[h]quinazolin-2(1H)-thione (5d)
Yellow solid; yield: 91%; mp: 234–237 C; IR (KBr, cm1)
tmax: 3192, 2920, 2824, 1671, 1173, 1124, 1082;
1H NMR
(CDCl3): d 1.91 (m, 1H), 2.06 (m, 1H), 2.71 (m, 2H), 3.80 (s,
6H), 5.03 (s, 1H), 6.56 (s, 1H), 6.77 (m, 2H), 6.88 (d,
J= 6.3 Hz, 2H), 7.14 (d, J= 6.3 Hz, 1H), 7.25 (d,
J= 6.6 Hz, 2H), 7.63 (s, 1H); 13C NMR (CDCl3): 174.2,
159.9, 159.7, 137.8, 133.5, 128.7, 125.6, 120.5, 120.2, 114.8,
114.4, 111.0, 108.0, 60.2, 55.3, 28.2, 23.5; MS: m/z= 352
(M+); Anal. Calcd for C20H20N2O2S: C, 68.16; H, 5.72; N,
7.95. Found: C, 67.82; H, 5.86; N, 8.14.
3.2.15. 3,4,5,6-Tetrahydro-8-methoxy-4-(3,4-dimethoxyp
henyl)benzo[h]quinazolin-2(1H)-thione (5e)
White solid; yield: 90%; mp: 253–255 C; IR (KBr, cm1) tmax:
3190, 2922, 2831, 1682, 1192, 1133, 1084; 1H NMR (CDCl3): d
1.93 (m, 1H), 2.06 (m, 1H), 2.72 (m, 2H), 3.81 (s, 3H), 3.86 (s,
3H), 3.88 (s, 3H), 5.04 (s, 1H), 6.80 (m, 6H), 7.16 (d,
J= 6.6 Hz, 1H), 7.66 (s, 1H); 13C NMR (CDCl3): 174.2,
158.8, 149.7, 147.9, 137.5, 137.1, 126.5, 123.0, 120.5, 120.3,
115.2, 113.7, 112.2, 110.8, 107.9, 58.0, 55.2, 54.2, 27.7, 23.5;
MS: m/z= 382 (M+); Anal. Calcd for C21H22N2O3S: C,
65.95; H, 5.80; N, 7.32. Found: C, 65.73; H, 5.91; N, 7.09.
3.2.16. 3,4,5,6-Tetrahydro-8-methoxy-4-p-tolylbenzo[h]quina
zolin-2(1H)-thione (5f)
Pale yellow solid; yield: 89%; mp: 248–251 C; IR (KBr, cm1)
tmax: 3197, 2983, 2931, 1674, 1188, 1136;
1H NMR (CDCl3): d
1.93 (m, 1H), 2.07 (m, 1H), 2.41 (s, 3H), 2.70 (m, 2H), 3.81 (s,
3H), 5.03 (s, 1H), 6.67 (m, 3H), 7.12 (d, J= 6.6 Hz, 2H), 7.37
(m, 3H), 8.98 (s, 1H); 13C NMR (CDCl3): 174.7, 159.3, 140.8,
138.1, 136.5, 129.0, 127.1, 126.9, 124.1, 121.4, 114.2, 111.2,
108.3, 58.2, 55.3, 27.9, 25.3, 23.7; MS: m/z= 336 (M+); Anal.
Calcd for C20H20N2OS: C, 71.40; H, 5.99; N, 8.33. Found: C,
71.16; H, 6.32; N, 8.52.
3.2.17. 3,4,5,6-Tetrahydro-4-(4-hydroxyphenyl)-8-methoxy
benzo[h]quinazolin-2(1H)-thione (5g)
Pale yellow solid; yield: 89%; mp: 268–270 C; IR (KBr, cm1)
tmax: 3412, 3173, 2925, 2812, 1656, 1167, 1055;
1H NMR
(CDCl3+DMSO-d6): d 1.94 (m, 1H), 2.06 (m, 1H), 2.69 (m,
2H), 3.80 (s, 3H), 4.92 (s, 1H), 6.77 (m, 4H), 7.15 (d,
J= 6.3 Hz, 2H), 7.32 (d, J= 6.3 Hz, 1H), 8.01 (s, 1H), 8.31
(s, 1H), 8.98 (s, 1H); 13C NMR (CDCl3+DMSO-d6): 174.2,
158.8, 156.6, 137.8, 136.4, 128.6, 126.5, 123.3, 120.4, 115.8,
114.0, 110.8, 108.2, 57.8, 55.3, 27.6, 23.6; MS: m/z= 339
(M+1); Anal. Calcd for C19H18N2O2S: C, 67.43; H, 5.36; N,
8.28. Found: C, 67.21; H, 5.48; N, 8.64.
3.2.18. 3,4,5,6-Tetrahydro-8-methoxy-4-(3-nitrophenyl)benzo
[h]quinazolin-2(1H)-thione (5h)
Yellow solid; yield: 87%; mp: 244–246 C; IR (KBr, cm1)
tmax: 3186, 2972, 2935, 1674, 1566, 1195, 1018;
1H NMR
(CDCl3): d 1.90 (m, 1H), 2.14 (m, 1H), 2.64 (m, 2H), 3.80 (s,
3H), 4.99 (s, 1H), 7.09 (m, 4H), 7.74 (m, 2H), 8.13 (d,
J= 6.3 Hz, 2H), 8.61 (s, 1H); 13C NMR (CDCl3): 175.0,
159.2, 148.3, 144.7, 139.1, 133.3, 129.6, 127.4, 124.1, 122.4,
120.9, 119.2, 114.5, 111.8, 108.5, 56.7, 55.6, 27.7, 24.2; MS:
m/z= 368 (M+1); Anal. Calcd for C19H17N3O3S: C, 62.11;
H, 4.66; N, 11.44. Found: C, 61.87; H, 4.75; N, 11.63.
S226 B. Janardhan et al.3.2.19. 4-(4-(Dimethylamino)phenyl)-3,4,5,6-tetrahydro-8-
methoxybenzo[h]quinazolin-2(1H)-thione (5i)
Yellow solid; yield: 86%; mp: 274–276 C; IR (KBr, cm1)
tmax: 3387, 3190, 2918, 2845, 1669, 1178, 1123, 1087;
1H
NMR (CDCl3): d 1.94 (m, 1H), 2.15 (m, 1H), 2.65 (m, 2H),
3.07 (s, 6H), 3.87 (s, 3H), 4.96 (s, 1H), 6.81 (m, 4H), 7.21
(m, 2H), 7.37 (d, J= 6.3 Hz, 2H), 8.47 (s, 1H); 13C NMR
(CDCl3): 174.2, 158.9, 147.7, 137.5, 133.3, 128.1, 126.7,
123.1, 120.4, 114.2, 113.9, 110.8, 107.9, 57.7, 55.1, 42.2, 27.6,
23.4; MS: m/z= 365 (M+); Anal. Calcd for C21H23N3OS:
C, 69.01; H, 6.34; N, 11.50. Found: C, 69.39; H, 6.02; N, 11.68.
3.2.20. 3,4,5,6-Tetrahydro-4-(4-hydroxy-3-methoxyphenyl)-8-
methoxybenzo[h]quinazolin-2(1H)-thione (5j)
Pale yellow solid; yield: 90%; mp: 264–266 C; IR (KBr, cm1)
tmax: 3422, 3179, 2924, 2846, 1698, 1187, 1145, 1087;
1H NMR
(CDCl3): d 1.93 (m, 1H), 2.14 (m, 1H), 2.65 (m, 2H), 3.75 (s,
3H), 3.81 (s, 3H), 4.98 (s, 1H), 7.11 (m, 6H), 8.06 (s, 1H),
8.33 (s, 1H), 8.98 (s, 1H); 13C NMR (CDCl3): 174.8, 158.9,
151.3, 143.8, 137.7, 137.4, 127.1, 123.4, 120.9, 121.4, 116.8,
113.8, 112.6, 110.9, 108.7, 58.0, 55.4, 54.2, 28.1, 24.3; MS: m/
z= 368 (M+); Anal. Calcd for C20H20N2O3S: C, 65.20; H,
5.47; N, 7.60. Found: C, 65.51; H, 5.33; N, 7.86.
4. Conclusion
In conclusion, we have developed an efﬁcient protocol for the
synthesis of fused 3,4-dihydropyrimidin-2(1H)-ones and thi-
ones under solvent-free conditions using a novel Bronsted acid
catalyst (P(4-VPH)HSO4). This protocol offers several advan-
tages such as high yield of products in short reaction times,
simple work-up procedure, easy isolation of the catalyst form
the reaction mixture, reusability of the catalyst and environ-
mentally benign nature. We believe this methodology is
superior to existing methodologies for the synthesis of fused
3,4-dihydropyrimidin-2(1H)-ones and thiones.
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